Silencing TTTY15 slows GC progression by acting on miR-98-5p and downregulating cyclin D2 (CCND2) expression, as corroborated by increased TTTY15 and CCND2 expression, and decreased miR-98-5p in GC tissues and cell lines [78]. Here, CCND2 is linked to gastric cancer.